Back to search

Article

Re-evaluating the Neutropenia–Survival Paradigm in Irinotecan-based Therapy for Advanced Gastric Cancer: Post-Hoc Analysis of the RINDBeRG Trial

2026-06-11

Abstract excerpt

<title>Abstract</title> <p>Background Chemotherapy-induced neutropenia (CIN) has been considered a favorable prognostic marker across multiple cytotoxic regimens for gastrointestinal malignancies. However, its prognostic relevance in irinotecan (IRI)-based therapy for advanced gastric cancer (AGC) remains unclear. Methods This post-hoc analysis used data from the phase III RINDBeRG trial comparing ramucirumab (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0581bf30-ad8f-51b2-b418-27ac50476092
DOI
10.21203/rs.3.rs-9835081/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Re-evaluating the Neutropenia–Survival Paradigm in Irinotecan-based Therapy for Advanced Gastric Cancer: Post-Hoc Analysis of the RINDBeRG TrialDOI 10.21203/rs.3.rs-9835081/v1
An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients.Semantic proximity
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model.Semantic proximity
ABCG2 genetic variant as risk factor for neutropenia in patients with metastatic or advanced hormone receptor -positive, HER2-negative breast cancer treated with palbociclibSemantic proximity
ABCG2 genetic polymorphism as risk factor for neutropenia in patients with metastatic or advanced hormone receptor -positive, HER2-negative breast cancer treated with palbociclibSemantic proximity
Comparison of Efficacy and safety of Tinapeg® vs. Neulastim® to prevent chemotherapy-induced neutropenia in breast cancer patients: randomized, parallel, equivalence, multicentric and Phase III clinical trial studySemantic proximity
UGT1A1*6 polymorphisms are correlated with irinotecan-induced neutropenia: a systematic review and meta-analysis.Semantic proximity
Derived neutrophil to lymphocyte ratio as a prognostic factor in patients with advanced colorectal cancer according to RAS and BRAF status: a post-hoc analysis of the MRC COIN study.Semantic proximity
Delayed chemotherapy-induced nausea – Occurrence and corelates in an international multi-center study in adult oncology patients in clinical practice (CINrate)Semantic proximity
Select a neighboring publication to make it the new centre.